Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01103921 · ClinicalTrials.gov registry record · NA
The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 214
- Enrollment target
NCT01103921: Completed NA study, sponsored by University of California, Davis.
NCT01103921 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 214 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01103921, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of consumption of sugar-sweetened beverages on blood triglycerides and cholesterol, cholesterol concentrations, and the body's sensitivity to insulin.
Primary Outcome
32 serial blood samples are collected over a 24 hour period.
Interventions
- OTHER Glucose
- OTHER Fructose
- OTHER High-Fructose Corn Syrup
- OTHER No sugar (Aspartame)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2008-10 |
| Est. Completion | 2014-01 |
| Phase | NA |
What the finished NCT01103921 record still lists
NCT01103921 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 4 interventions - of which Glucose is the first listed.
NCT01103921 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01103921 about?
NCT01103921 is a clinical study titled "The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks". The purpose of this study is to examine the effects of consumption of sugar-sweetened beverages on blood triglycerides and cholesterol, cholesterol concentrations, and the body's sensitivity to insulin.
What is the current status of trial NCT01103921?
This trial is currently completed. It is a NA study. The enrollment target is 214 participants. The study started on 2008-10. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01103921?
The interventions under investigation include: Glucose (OTHER), Fructose (OTHER), High-Fructose Corn Syrup (OTHER), No sugar (Aspartame) (OTHER).
Who is sponsoring clinical trial NCT01103921?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01103921's enrollment target sits among peer trials
214 487th of 2000 higher than 1,513 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia